Screener
McKesson MCK Prescription Technology Solutions — Total segment depreciation and amortization
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by McKesson in its filing.
Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.
The source filing: McKesson’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:29 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000927653-26-000234
| (In millions) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 |
|---|---|---|
| Segment depreciation and amortization (7) | ||
| North American Pharmaceutical | $39 | $32 |
| Oncology & Multispecialty | 66 | 42 |
| Prescription Technology Solutions | 19 | 21 |
| Medical-Surgical Solutions | 26 | 22 |
| Other | — | 3 |
| Corporate | 45 | 37 |
| Total segment depreciation and amortization | $195 | $157 |
Item 1. Condensed Consolidated Financial Statements.
FAQ
- What is McKesson's prescription technology solutions — total segment depreciation and amortization?
- McKesson (MCK) reported prescription technology solutions — total segment depreciation and amortization of $19M in Q2 2026.
- How has McKesson's prescription technology solutions — total segment depreciation and amortization changed year-over-year?
- McKesson's prescription technology solutions — total segment depreciation and amortization decreased by 9.5% year-over-year, from $21M to $19M.
- What is the long-term trend for McKesson's prescription technology solutions — total segment depreciation and amortization?
- Over 4 years (2022 to 2026), McKesson's prescription technology solutions — total segment depreciation and amortization has grown at a 0.0% compound annual growth rate (CAGR), from $82M to $82M.
- What does prescription technology solutions — total segment depreciation and amortization mean?
- This metric represents the total non-cash charges for the depreciation of tangible assets and the amortization of intangible assets within the Prescription Technology Solutions segment. It reflects the consumption of capital investments over time. High levels often correlate with significant past acquisitions or heavy investment in software platforms.
Ask your AI about McKesson's prescription technology solutions — total segment depreciation and amortization.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude